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Case ReportRobot-Assisted Laparoscopic Vesiculectomy for
Large Seminal Vesicle Cystadenoma: A Case
Report and Review of the Literature
Riccardo Campi,1 Sergio Serni,1 Maria Rosaria Raspollini,2 Agostino Tuccio,1
Giampaolo Siena,1 Marco Carini,1 Andrea Minervini1Clinical Practice Points
 Primary tumors of seminal vesicles (SVs) are very rare.
Differential diagnosis often relies on a multimodality
approach comprising magnetic resonance imaging
and preoperative biopsies.
 We report a case of a large SV cystadenoma causing
gross hematuria and lower urinary tract symptoms
managed with nerve-sparing, robot-assisted laparo-
scopic seminal vesiculectomy.
 Most cases of SV cystadenoma reported in published
studies were managed with open, invasive surgical
approaches. To date, laparoscopic and robotic semi-
nal vesiculectomy can be safely considered the
reference standard treatment of benign tumors of SVs,
because they combine a minimally invasive approach
with optimal surgical, oncologic, and functional
outcomes.Clinical Genitourinary Cancer, Vol. 13, No. 5, e369-73 ª 2015 Elsevier Inc. All rights reserved.
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Clinical Case
A 47-year-old patient had been referred to our center for gross
hematuria and lower urinary tract symptoms (LUTS). His medical
history was unremarkable, and no comorbidities were present. The
prostate-specific antigen (PSA) level was 1.7 ng/mL. The digital
rectal examination revealed a tense and elastic mass with undefined
boundaries, cranially to the prostate. The physical examination and
laboratory test results were otherwise normal. Transabdominal ul-
trasonography showed no lesions in the upper urinary tract; how-
ever, high-resolution transrectal ultrasonography (TRUS) confirmed
the presence of a multiseptated, solid-cystic pelvic mass occupying
the retrovesical space. No suspected areas were detected in the pe-
ripheral zone of the prostate. In-office cystoscopy was performed to
rule out a bladder malignancy. No lesions were found within the
bladder; however, unusual bleeding from the seminal colliculus was1Department of Urology
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http://dx.doi.org/10.1016/j.clgc.2015.02.011found. The right ureteral orifice had also been pushed cranially,
likely by extrinsic compression.
Diagnostic Assessment and Magnetic Resonance
Imaging Findings
The patient underwent a urography-computed tomography
scan, which confirmed the presence of a large mass with undefined
boundaries and poor contrast enhancement occupying the retro-
vesical space. The relationships among the mass, rectum, and
bladder were unclear. No abnormalities of the upper urinary tract
and no pathologic pelvic lymph nodes were found. To further
characterize the nature of the mass and to analyze its relationships
with the adjacent organs, magnetic resonance imaging was per-
formed. A retrovesical 6.0-  4.5-cm, well-defined, pseudonodular
mass, arising from the right seminal vesicle (SV) and vas deferens
(VD), was found cranial to the prostate (Figure 1). The signal was
irregular and heterogeneous on T1-weighted images, likely owing
to mixed serous-hemorrhagic remains. TRUS-guided prostate and
SV biopsies were performed to exclude primary or secondary
malignancies. No neoplastic proliferation was found in any of the
samples from the prostate and SV mass.
Management and Outcome
The patient was scheduled for nerve-sparing (NS) robot-assisted
laparoscopic vesiculectomy (RALV). A 4-arm transperitonealClinical Genitourinary Cancer October 2015 - e369
Figure 1 Magnetic Resonance Imaging Findings of the Pseudonodular Mass Arising From the Right Seminal Vesicle. (A) Axial
T1-weighted Image Showing a Hyperintense, Heterogeneous Signal With No Pathologic Contrast Enhancement After
Administration of Contrast Medium. No Pathologic Pelvic Lymph Nodes Were Visible. Axial (B), Sagittal (C), and Coronal
(D) T2-weighted Images Showing the Well-Defined Pelvic Mass and Its Relationship With the Adjacent Organs. No Signs
Were Seen of Local Spread, and the Adipose Tissue Between the Mass and Rectum Was Well Preserved
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e370approach, using a 0 lens, was adopted. After a transversal incision
of the peritoneum at the level of the Douglas pouch, a voluminous
mass, firmly adherent to the prostate, the left SV, and surrounding
tissues, was found. The plane between the mass, rectum, and
bladder was carefully and bluntly developed using monopolar
scissors and, if needed, a bipolar Maryland dissector, until the
tumor had been completely released from the surrounding adhe-
sions. The left VD and SV were preserved during the dissection.
The neurovascular bundles were approached bilaterally in an
athermal, traction-free manner to preserve continence and po-
tency. The specimen was then removed intact through the camera
port using a retrieval bag. Accurate hemostatic control was ach-
ieved, and a tube drain was positioned. The console time and
estimated blood loss was 120 minutes and 50 mL, respectively. No
intraoperative complications were recorded. The postoperative
course was uneventful, and the patient was discharged on the
fourth postoperative day with normal blood test results and
spontaneous voiding. The 2-year follow-up examination showed
no evidence of disease recurrence. At the last follow-up examina-
tion, the patient was free of symptoms with full preservation of
continence and potency.- Clinical Genitourinary Cancer October 2015Histopathologic Analysis
The histopathologic examination showed a 7.0  4.5  4.5-cm
SV cystadenoma, according to the World Health Organization
(WHO) classification criteria (Figure 2).1 The stroma resembled the
usual fibromuscular stroma of SVs. No significant cytologic atypia,
mitotic activity, or necrosis was present. The histochemical panel
showed modest positivity for cytokeratin (CK) 7, and the PSA,
prostatic acid phosphatase, and CK20 test results were negative. The
proliferation index, determined using the immunohistochemical
assay and Ki67, was < 1%.
Discussion
Primary diseases of the SVs are very rare. Benign tumors can
appear as complex, solid cystic retrovesical masses1 and are often
totally asymptomatic. However, they can also lead to LUTS and
unspecific signs, such as hematuria, hematospermia, perineal or
postcoital discomfort, and painful defecation.2 Occasionally, infer-
tility will be the main feature. The differential diagnosis can be
challenging because other pathologic entities, such as SV cysts,
diverticula of the ejaculatory ducts, acute inflammatory diseases,
abscesses, amyloidosis, and malignancies (mostly arising from the
Figure 2 Surgical Specimen and Histopathologic Analysis. (A) Gross Photograph of the Seminal Vesicle Cystadenoma in Relation
to the Deferent Tract. Macroscopically, the Tumor Was Well Defined, Showing a Glistening, Smooth, Tan Surface. (B) The
Cut Surface Revealed Multilocular Cysts of Different Shapes Containing Gelatinous Fluid. (C) Histologically, at Low
Magnification, the Tumor Was Composed by Multiple Cystic Glandular Branching Formations Separated by a Spindle Cell
Stroma. The Cysts Contained Amorphous Eosinophilic Material. (D) At High Magnification, the Simple Cuboidal/Low
Columnar Epithelium of the Cysts Is Seen. Nuclei Are Round and Regular. No Significant Cytologic Atypia, Mitotic Activity,
and Necrosis Were Present
Riccardo Campi et alprostate, bladder, or rectum) can show the same imaging features.3
Therefore, the differential diagnosis must use a multimodality
approach. The overall preoperative characterization of the tumor is
critical to identify the most appropriate surgical strategy, with the
first priority the exclusion of a primary or secondary malignancy.
We have presented a case of a large SV cystadenoma managed
with NS RALV. A review of the English-language published studies
of SV cystadenoma was performed using the Medline, Embase, and
Web of Science databases to October 2014. Twenty case reports
have been published on SV cystadenoma (Table 1). The median
patient age and median tumor diameter was 49 years (interquartile
range [IQR], 42-51 years) and 7.0 cm (IQR, 5.0-12.0 cm),
respectively. No perioperative complications were reported in the
published series. Local recurrence developed in 2 patients (10%)
after 2 and 3 years, respectively. Nonetheless, the follow-up period
was highly variable among the studies. The differential use of
diagnostic investigations and surgical approaches for SV cys-
tadenoma in the published series is shown in Figure 3. Analyzing
the current published data, the most useful diagnostic investigations
for the detection and characterization of SV cystadenoma were
TRUS, MRI, and preoperative biopsy. The findings from cystos-
copy and other techniques usually integrated the diagnosis. The
diagnostic workup should always exclude congenital abnormalities
of the upper urinary tract, especially renal agenesis. Owing to its
multiplanar capability and excellent tissue contrast and resolution,endorectal MRI is the most accurate tool to accurately define the
anatomic relationships of the tumor during surgical planning.3
When the imaging findings are unspecific or inconclusive,
TRUS-guided focused biopsies are critical to obtain a precise his-
topathologic characterization of the lesion. Cystadenoma must be
distinguished from mixed epithelial-stromal tumors (MEST) of SVs,
which has been reported in previous studies with many different
names.4 Currently, specific histological criteria must be fulfilled for
the definition of MESTs, and the WHO classification has clearly
separated this entity from cystadenoma.1,3 The differential diag-
nosis, based on the histologic analysis of the tumor stroma, is an
important prognostic factor. Although MESTs usually show benign
behavior, they can express histologic and clinical characteristics of
malignancy4 and could potentially require more radical options. In
contrast, seminal vesiculectomy is the recommended treatment of
SV solid masses that are benign on biopsy, if symptomatic and with
no evidence of local spread.2
Various surgical approaches have been described in published
studies for SV cystadenoma. Owing to the anatomic location,
surgical access to the SVs can be challenging, and the decision
mainly relies on the expertise of the surgeon.2 Most cases in the
published studies were managed with an open technique using
an anterior transvesical5 or a retrovesical6 approach. Radical
cystoprostatovesiculectomy has also been performed.7 After the
first report of the use of a laparoscopic approach to SVs byClinical Genitourinary Cancer October 2015 - e371
Table 1 Strategies for Diagnosis and Surgical Approaches for Seminal Vesicle Cystadenoma According to Published Series
Study
Patient
Age (years)
Tumor Size
(Greatest
Diameter) (cm)
Diagnostic
Strategy
Surgical
Procedure
Perioperative
Complication
Local Recurrence
After Surgery
(years)
Soule et al16, Proc Staff Meet
Mayo Clin, 1951
47 14 Open (conservative) No No
Damjanov et al17, J Urol, 1974 52 5.5 Autopsy No No
Lundhus et al18, Scand J Urol
Nephrol, 1984
39 7.4 Open (CysProV) No No
Mazur et al19, Am J Surg Pathol,
1987
49 7 Open (conservative) No Yes (2)
Bullock et al20, J R Soc Med, 1988 59 12 LV No Yes (3)
Raghuveer et al21, Indian J Pathol
Microbiol, 1989
Mazzucchelli et al22, J Urol, 1992 63 3 Open (conservative) No No
Ranschaert et al23, J Belge Radiol,
1992
50 12 Open (conservative) No No
Lagalla et al24, Abdom Imaging,
1993
33 TRUS, CT, FNA,
cytology, biopsy
Open (conservative) No No
Santos et al25, Pathology, 2001 49 15 Open (conservative) No No
Gil et al26, Int Braz J Urol, 2003 49 7 Abd US, CT, MRI Open (conservative,
retrovesical approach)
No No
Lee et al,6 Int J Urol, 2006 46 7.5 CT, MRI, explorative
laparotomy
Open (conservative) No No
Lorber et al,5 Eur Urol, 2011 52 14 CT, MRI, Abd US,
biopsy
Open (conservative,
transvesical)
No No
Kural et al,14 J Endourol, 2011 48 6 TRUS, biopsy RALV No No
Ploumidis et al,15 Int J Surg
Case Rep, 2012
45 17.2 TRUS, CT, MRI, CYS,
FNA-cytology,
intraoperative biopsy
RALV No No
Arora et al27, Urology, 2013 23 TRUS, MRI Open (conservative) No No
Zhu et al,11 Asian J Androl, 2013 31 5 CT, MRI LV No No
Zhang et al,13 Urology, 2013 32 5 LV No No
Zhang et al,13 Urology, 2013 64 4.5 LV No No
Zhang et al,13 Urology, 2013 50 3.8 LV No No
Abbreviations: Abd US ¼ abdominal ultrasonography; CT ¼ computed tomography; CYS ¼ cystoscopy; CysProV ¼ cystoprostatovesiculectomy; FNA ¼ fine needle aspiration; LV ¼ laparoscopic
vesiculectomy; MRI ¼ magnetic resonance imaging; TRUS ¼ transrectal ultrasonography.
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been increasingly performed to approach retrovesical structures
such as tumors or cysts.9 Transperitoneal laparoscopic ves-
iculectomy for SV cystadenoma was recently performed,
achieving optimal oncologic outcomes and easy recovery after
surgery.10,11 With the advantages over conventional laparoscopy,
in particular, the magnified 3-dimensional vision, EndoWrist
instrument technology, and superior ergonomic environment for
the operating surgeon, a robotic approach has been increasingly
selected for the treatment of cysts and other abnormalities of the
SVs.12,13 To date, only 2 cases of SV cystadenoma have been
managed with RALV using a transperitoneal approach.14,15 This
technique replicates the surgical principles of posterior approach
to SVs during robot-assisted radical prostatectomy (RARP). In
this context, some investigators have recommended previous
experience in RARP before approaching a retrovesical mass with
the robotic technique.15
In the present case, the diagnostic workup could safely exclude
primary or secondary malignancies of the SVs, avoiding any need for
intraoperative biopsies. NS RALV provided easy access to the- Clinical Genitourinary Cancer October 2015retrovesical anatomic structures, with optimal exposure of the SV
mass and guaranteed optimal functional and oncologic outcomes.
Although most reported cases of SV cystadenoma were managed
with open surgery, MIS can be considered the new reference stan-
dard for the treatment of such benign tumors. Additional studies are
needed to confirm the feasibility and oncologic safety of this
technique.
Conclusion
We have presented a case of a large SV cystadenoma causing
LUTS and gross hematuria managed by NS RALV. Primary tumors
of SVs are very rare. The differential diagnosis can be challenging
and must use a multimodality approach. Once the benign nature of
the tumor has been confirmed at preoperative biopsy, minimally
invasive seminal vesiculectomy can achieve optimal perioperative
and oncologic outcomes and can be safely considered the standard
reference treatment.Disclosure
The authors have stated that they have no conflicts of interest.
Figure 3 Overview of the Differential Use of Diagnostic Investigations and Surgical Treatment Options for Seminal Vesicle
Cystadenoma Among Published Series. (A) In 10 of 20 Studies (50%), the Diagnostic Workup Was Accurately Described.
Ultrasonography (US) Was Used in 6 Cases (60%), Endorectal Magnetic Resonance Imaging (MRI) in 7 (70%), Computed
Tomography (CT) in 6 (60%), Preoperative Biopsy in 4 (40%), Intraoperative Biopsy and Explorative Laparotomy in 1 Case
(10%) Each, Cystoscopy, Fine Needle Aspiration, Cytology, and Other Modalities in 2 (20%). Finally, 1 Case (10%) Was Found
at Autopsy. (B) In 19 of 20 Studies (95%), the Surgical Technique Was Well Defined. An Open Approach Was Used in Most
Cases, With Tumorectomy (Tum) in 11 Cases (58%) and Radical Cystoprostatovesiculectomy (CysProV) in 1 (5%).
Laparoscopic Vesiculectomy (LV) and Robot-Assisted LV (RALV) Was Performed in 5 (26%) and 2 (11%) Cases, Respectively
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